Bio-Connect
Human IL-22 PicoKine ELISA Kit standard curve
Human IL-22 PicoKine ELISA Kit standard curve
Human IL-22 PicoKine ELISA Kit standard curve

Human IL-22/Interleukin-22 ELISA Kit PicoKine(r)

EK0933
Boster Bio
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human IL-22 PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    15.6 pg/ml - 1,000 pg/ml
  • Assay Sensitivity
    <10 pg/ml
  • Assay Time
    20-25
  • Certification
    Research Use Only
  • Scientific Description
    Human IL-22 ELISA Kit PicoKine® (96 Tests). Quantitate Human IL22 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity Supplier
    Human IL-22
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Atas N, Çakır B, Bakır F, et al. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. Clin Rheumatol. 2022,41(5):1381-1389. doi: 10.1007/s10067-022-06070-w
    Read this paper
  • Sun W, Gao Y, Yu X, et al. 'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways. Mol Med Rep. 2018,18(3):2733-2743. doi: 10.3892/mmr.2018.9262
    Read this paper
  • Min M, Yan BX, Wang P, et al. Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies. PLoS One. 2017,12(12):e0190051. doi: 10.1371/journal.pone.0190051
    Read this paper
  • Zhang J, Chen SL, Li LB. Correlation between intestinal flora and serum inflammatory factors in patients with Crohn's disease. Eur Rev Med Pharmacol Sci. 2017,21(21):4913-4917.
    Read this paper